Authors: Silverberg, DS Wexler, D Sheps, D Blum, M Keren, G Baruch, R Schwartz, D Yachnin, T Steinbruch, S Shapira, I Laniado, S Iaina, A

Citation: Ds. Silverberg et al., The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study, J AM COL C, 37(7), 2001, pp. 1775-1780

Authors: Silverberg, DS Blum, M Agbaria, Z Deutsch, V Irony, M Schwartz, D Baruch, R Yachnin, T Steinbruch, S Iaina, A

Citation: Ds. Silverberg et al., The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period, CLIN NEPHR, 55(3), 2001, pp. 212-219

Authors: Silverberg, DS Wexler, D Blum, M Keren, G Sheps, D Leibovitch, E Brosh, D Laniado, S Schwartz, D Yachnin, T Shapira, I Gavish, D Baruch, R Koifman, B Kaplan, C Steinbruch, S Iaina, A

Citation: Ds. Silverberg et al., The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduceshospitalizations, J AM COL C, 35(7), 2000, pp. 1737-1744

Authors: Silverberg, DS Blum, M Agbaria, Z Schwartz, D Zubkov, A Yachnin, T Iaina, A

Citation: Ds. Silverberg et al., Intravenous iron for the treatment of predialysis anemia, KIDNEY INT, 55, 1999, pp. S79-S85